INHOMEPHARMACY LLC — Department of Defense SBIR Phase I: J201-CSO1
INHOMEPHARMACY LLC — SBIR Phase I award from Department of Defense.
- Amount
- $50,000
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- J201-CSO1
- Solicitation
- X20.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-03-09 → 2020-06-09
Description
InHomePharmarcy (IHP) is the parent company that produces the health and wellness platform “IHPHealth.” This platform employs AI to provide a comprehensive coverage to patients and caregiver health care concerns. IHP operates long-range, low power IoT applications to integrate wearable IHPWear sensors and a medication focused AI BudhiBot that provides AI managed oversight at any location to securely disburse measured and verified pharmaceuticals. This secure platform monitors and analyzes patient and caregiver interaction, medicinal intake, and patient well-being through an AI management process that produces real-time accessible data for analysis to improve the operational effectiveness and health of the warfighter. When used in conjunction (the BudhiBot and IHPWear), patient medication adherence can be documented as well as ingestion of medications to close the loop on medication adherence and efficacy.